GO:0004161 dimethylallyltranstransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004161 (dimethylallyltranstransferase activity) catalyzes the condensation of dimethylallyl diphosphate (DMAPP) with isopentenyl diphosphate (IPP) to form (2E)-geranyl diphosphate and diphosphate.
• This prenyltransferase activity is the first committed step in the biosynthesis of geranyl, farnesyl, and longer prenyl chains that serve as substrates for protein prenylation and natural product biosynthesis.
• Enzymes with this activity are found across bacteria, fungi, plants, and animals, and include both canonical chain-elongating prenyltransferases and aromatic prenyltransferases with broader substrate tolerance.
• Structural and biochemical studies have revealed that these enzymes use a conserved all-α-helical fold and a diphosphate-binding pocket to orient DMAPP and IPP for sequential condensation.
• Dysregulation of prenyltransferase activity is linked to cancer, metabolic disorders, and infections, making it a target for drug discovery and metabolic engineering.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise interrogation of GO:0004161 enzymes in disease and biotechnology contexts.
Description
Dimethylallyltranstransferase activity (GO:0004161) is a molecular function that catalyzes the condensation of dimethylallyl diphosphate (DMAPP) with isopentenyl diphosphate (IPP) to produce (2E)-geranyl diphosphate and diphosphate. This reaction represents the first step in the sequential elongation of prenyl chains, generating geranyl diphosphate (GPP), which can be further extended to farnesyl diphosphate (FPP) and longer isoprenoids. The activity is essential for the biosynthesis of primary metabolites such as sterols, ubiquinones, and dolichols, as well as for the prenylation of proteins and natural products. Researchers study GO:0004161 to understand how cells allocate isoprenoid precursors, how prenyltransferases achieve substrate specificity, and how these enzymes contribute to disease and microbial secondary metabolism. The reaction is also a focal point for metabolic engineering, as modulating this activity can redirect flux toward high-value terpenoids or away from pathogenic prenylated metabolites. Given its central role in isoprenoid metabolism, GO:0004161 is a key node linking basic enzymology to translational applications in cancer, infectious disease, and biotechnology.
dimethylallyltranstransferase activity At A Glance
| GO ID | GO:0004161 |
|---|---|
| GO term | dimethylallyltranstransferase activity |
| Ontology | molecular_function |
| Synonym | geranyl diphosphate synthase activity; DMAPP:IPP-dimethylallyltransferase activity; trans-farnesyl pyrophosphate synthetase activity; diprenyltransferase activity |
| Major function | Catalyzes the condensation of DMAPP and IPP to form (2E)-geranyl diphosphate and diphosphate |
| Reaction | dimethylallyl diphosphate + isopentenyl diphosphate = (2E)-geranyl diphosphate + diphosphate |
| Substrates | DMAPP and IPP |
| Products | (2E)-geranyl diphosphate and diphosphate |
| Pathway context | Isoprenoid biosynthesis; prenyl chain elongation |
What Is GO:0004161?
In my own words, GO:0004161 describes the catalytic activity of an enzyme that joins DMAPP and IPP through a head-to-tail condensation, releasing diphosphate and forming the 10-carbon molecule (2E)-geranyl diphosphate. This is the initial step in the prenyl chain elongation pathway that produces longer prenyl diphosphates such as farnesyl diphosphate and geranylgeranyl diphosphate, which are used for protein prenylation and for the biosynthesis of terpenoids and other natural products.
Why Is dimethylallyltranstransferase activity Important in Cell Biology?
GO:0004161 is important because it initiates the prenyl chain elongation pathway that supplies geranyl diphosphate, a precursor for farnesyl diphosphate and geranylgeranyl diphosphate, which are required for protein prenylation, sterol biosynthesis, and the production of numerous secondary metabolites. Perturbations in this activity can alter cell signaling, membrane trafficking, and metabolic flux, with consequences for cancer, metabolic disorders, and microbial pathogenesis. Understanding its mechanism also supports the rational design of inhibitors and the engineering of enzymes for biotechnological applications.
• Provides the first committed step in the biosynthesis of geranyl, farnesyl, and geranylgeranyl diphosphates.
• Supplies prenyl groups for protein prenylation, a post-translational modification critical for Ras, Rho, and Rab GTPase function.
• Contributes to the biosynthesis of sterols, ubiquinones, dolichols, and other essential isoprenoids.
• Plays a role in the production of prenylated natural products, including indole alkaloids and flavins.
• Is a potential target for anticancer, antimicrobial, and antiparasitic drug development.
• Enables metabolic engineering of terpenoid pathways in microbial and plant systems.
• Its substrate promiscuity can be exploited for chemoenzymatic synthesis of novel prenylated compounds.
• Dysregulation of prenyltransferase activity has been associated with cancer progression and metabolic syndromes.
• Enzymes with this activity are used as biocatalysts for regio- and stereo-selective prenylation.
• Studying GO:0004161 helps clarify the evolutionary relationships among prenyltransferases across kingdoms.
Molecular Mechanism of dimethylallyltranstransferase activity
Substrate Binding and Orientation
In simple terms: The enzyme grabs DMAPP and IPP and holds them in the right positions for a chemical reaction.
Enzymes with dimethylallyltranstransferase activity bind DMAPP and IPP in a conserved diphosphate-binding pocket, often stabilized by divalent metal ions such as Mg2+ or Mn2+. Structural studies of all-α-helical prenyltransferases show that the DMAPP allylic diphosphate is positioned for attack by the IPP double bond, while the IPP is oriented to facilitate head-to-tail condensation. Aromatic prenyltransferases can accept a broader range of substrates, but they share a similar mode of diphosphate recognition.
Catalytic Condensation and Product Release
In simple terms: The two molecules join together, and the new geranyl diphosphate molecule is released.
The catalytic mechanism involves an electrophilic attack of the DMAPP carbocation (generated upon diphosphate departure) on the IPP double bond, forming a new carbon-carbon bond and yielding (2E)-geranyl diphosphate. The reaction is thought to proceed through a concerted or stepwise ionization-condensation-elimination pathway, with the enzyme stabilizing the allylic cation intermediate. Product release is facilitated by conformational changes that open the active site, as observed in multiple prenyltransferase structures.
Cofactors and Metal Dependence
In simple terms: Some of these enzymes need metal helpers to work efficiently.
Many dimethylallyltranstransferases require divalent metal ions (e.g., Mg2+ or Mn2+) for optimal activity, which help neutralize the negative charge of the diphosphate groups and stabilize the transition state. However, some aromatic prenyltransferases are metal-independent and rely on conserved arginine or lysine residues for diphosphate binding. The metal dependence can vary among homologs and is an important consideration for in vitro assays.
Substrate Specificity and Promiscuity
In simple terms: Some enzymes are picky about their substrates, while others can use a variety of similar molecules.
Canonical chain-elongating prenyltransferases are highly specific for DMAPP and IPP, whereas aromatic prenyltransferases often display relaxed specificity, accepting various aromatic acceptors and prenyl donors. This promiscuity has been exploited for the chemoenzymatic synthesis of prenylated indole alkaloids and flavins. Structural determinants of specificity include the size and shape of the acceptor-binding pocket and the presence of flexible loops that gate substrate access.
Regulation of Enzyme Activity
In simple terms: Cells can turn these enzymes on or off to control how much geranyl diphosphate is made.
Dimethylallyltranstransferase activity is regulated at multiple levels, including transcriptional control of the encoding genes, feedback inhibition by downstream isoprenoid products (e.g., farnesyl diphosphate or geranylgeranyl diphosphate), and post-translational modifications. In some organisms, the enzyme is part of a multi-enzyme complex that channels substrates efficiently. Additionally, the availability of DMAPP and IPP, which are produced by the mevalonate or MEP pathways, directly influences the reaction rate.
Key Genes Involved in GO:0004161 dimethylallyltranstransferase activity
The following genes encode enzymes that exhibit dimethylallyltranstransferase activity or are directly involved in the prenyl chain elongation pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| fni (Tolypocladium inflatum) | Multiple prenyltransferase with DMAPP:IPP activity | Biochemical characterization and natural product biosynthesis |
| idsA (Bacillus subtilis) | Geranyl diphosphate synthase | Model for bacterial isoprenoid biosynthesis |
| GGPPS1 (Arabidopsis thaliana) | Geranylgeranyl diphosphate synthase | Plant prenyltransferase structure-function |
| FDPS (Homo sapiens) | Farnesyl diphosphate synthase | Target for bisphosphonate drugs and cancer |
| GGPS1 (Homo sapiens) | Geranylgeranyl diphosphate synthase | Protein prenylation and cancer |
| EchPT1 (fungal) | Aromatic prenyltransferase | Prenylation of cyclic dipeptides |
| TleC (Streptomyces) | Aromatic prenyltransferase | Teleocidin biosynthesis |
| FtmPT1 (Aspergillus fumigatus) | Indole prenyltransferase | Structural basis of prenylation |
| CdpNPT (Aspergillus) | Cyclic dipeptide prenyltransferase | Substrate multiplexed assays |
| PT1 (plant) | Geranyl diphosphate synthase | Monoterpene biosynthesis |
| PT2 (plant) | Farnesyl diphosphate synthase | Sesquiterpene biosynthesis |
| DMATS (Aspergillus) | Dimethylallyltryptophan synthase | Aromatic prenylation model |
| FgaPT2 (Aspergillus) | Farnesyltransferase | Flavin prenylation |
| Mvd1 (Saccharomyces cerevisiae) | Mevalonate diphosphate decarboxylase | Upstream DMAPP supply |
| ERG20 (Saccharomyces cerevisiae) | Farnesyl diphosphate synthase | Yeast isoprenoid engineering |
| GGPPS (Escherichia coli) | Geranylgeranyl diphosphate synthase | Bacterial prenyltransferase |
| HIS7 (Saccharomyces cerevisiae) | Feedback regulation of isoprenoid pathway | Metabolic control |
How Is dimethylallyltranstransferase activity Regulated?
Dimethylallyltranstransferase activity is regulated by feedback inhibition from downstream products such as farnesyl diphosphate and geranylgeranyl diphosphate, which bind to allosteric sites and reduce catalytic turnover. Transcriptional regulation of the encoding genes responds to cellular demand for isoprenoids, and in some organisms, the enzyme is part of a metabolon that channels substrates. Post-translational modifications, including phosphorylation, can also modulate activity. Additionally, the availability of DMAPP and IPP, controlled by the mevalonate and MEP pathways, directly affects the reaction rate.
dimethylallyltranstransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FDPS | Cancer, bone metastasis | Knockout in cancer cell lines; point mutation to mimic bisphosphonate resistance |
| GGPS1 | Cancer, protein prenylation defects | Knock-in of patient mutations; overexpression in HEK293 |
| EchPT1 | Fungal secondary metabolism | Knockout in Aspergillus; heterologous expression in E. coli |
| TleC | Teleocidin biosynthesis | Knockout in Streptomyces; point mutations in active site |
| FtmPT1 | Indole prenylation | Overexpression in E. coli; site-directed mutagenesis |
Cancer and Protein Prenylation
Protein prenylation, which depends on prenyl donors produced by GO:0004161, is essential for the membrane localization and function of Ras, Rho, and Rab GTPases. Dysregulation of prenyltransferase activity can lead to aberrant activation of these signaling proteins, contributing to cancer cell proliferation and survival. Inhibitors of farnesyl diphosphate synthase, such as bisphosphonates, have been investigated for anticancer activity.
Metabolic Disorders and Isoprenoid Biosynthesis
Mutations or altered expression of enzymes with dimethylallyltranstransferase activity can disrupt the balance of isoprenoid metabolites, affecting cholesterol synthesis and mitochondrial function. This has been linked to metabolic syndromes and rare inherited disorders of isoprenoid metabolism.
Infectious Disease and Natural Product Biosynthesis
Many pathogenic fungi and bacteria use prenyltransferases to produce virulence factors or secondary metabolites. For example, teleocidin B biosynthesis in Streptomyces involves aromatic prenyltransferases, and fungal prenyltransferases contribute to mycotoxin production. Targeting these enzymes is a potential antimicrobial strategy.
From dimethylallyltranstransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GO:0004161 enzyme affect cell viability? | CRISPR knockout in human cell lines (e.g., HAP1, HeLa) |
| How does a specific point mutation alter substrate specificity? | CRISPR point mutation knock-in in endogenous locus |
| Can a tagged version reveal subcellular localization? | Knock-in of GFP or FLAG tag at the N- or C-terminus |
| What is the effect of enzyme overexpression on isoprenoid flux? | Overexpression via lentiviral transduction or CRISPR activation |
| Which genes interact with the prenyltransferase pathway? | CRISPR library screening with metabolic readouts |
| Can the enzyme be engineered for novel substrate acceptance? | Directed evolution combined with CRISPR knock-in |
How to Study the dimethylallyltranstransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay with radiolabeled IPP | Catalytic activity of prenyltransferases | Kinetic characterization of wild-type and mutant enzymes |
| LC-MS/MS | Product formation (e.g., geranyl diphosphate) | Substrate specificity profiling |
| X-ray crystallography | Three-dimensional structure of enzyme-substrate complexes | Mechanistic studies and inhibitor design |
| CRISPR knockout | Loss-of-function phenotype | Determining essentiality in cell lines |
| CRISPR point mutation knock-in | Effect of specific amino acid changes | Structure-function analysis |
| RNA-seq | Transcriptional changes upon perturbation | Pathway crosstalk analysis |
| CRISPR library screening | Genes that modulate sensitivity to inhibitors | Target discovery |
| Isothermal titration calorimetry | Binding affinity for substrates | Quantifying enzyme-substrate interactions |
Enzymatic Assays for Prenyltransferase Activity
In vitro assays using recombinant enzymes and radiolabeled or fluorescently labeled DMAPP and IPP are standard for measuring dimethylallyltranstransferase activity. These assays can be coupled to HPLC or mass spectrometry to identify products such as geranyl diphosphate. Substrate-multiplexed assays allow simultaneous testing of multiple prenyl donors and acceptors.
Structural Biology and Biophysics
X-ray crystallography and cryo-EM have been used to determine the structures of several prenyltransferases, revealing the all-α-helical fold and substrate-binding pockets. Isothermal titration calorimetry and surface plasmon resonance can quantify substrate binding affinities.
Genetic and Genomic Approaches
CRISPR-Cas9 knockout, point mutation, and knock-in models enable functional studies in native cellular contexts. RNA-seq and proteomics can assess downstream effects on isoprenoid-related genes and proteins. CRISPR library screening can identify synthetic lethal interactions.
Metabolic Flux Analysis
Stable isotope labeling combined with mass spectrometry can track carbon flux through the prenyl chain elongation pathway. This approach helps quantify how changes in GO:0004161 activity affect the production of downstream isoprenoids.
How CRISPR Can Be Used to Study GO:0004161 dimethylallyltranstransferase activity
Knockout
CRISPR knockout of genes encoding dimethylallyltranstransferase activity can reveal their essentiality and impact on isoprenoid flux. For example, knocking out FDPS in cancer cell lines reduces protein prenylation and inhibits proliferation. Knockout models are also used to study the role of these enzymes in microbial secondary metabolism.
Point Mutation
Introducing precise point mutations in the catalytic pocket of prenyltransferases via CRISPR can dissect the contribution of individual residues to substrate binding and catalysis. Such models help validate structural predictions and identify residues critical for activity.
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) or patient-derived mutations allows tracking of enzyme localization and function in live cells. This approach is valuable for studying how mutations in prenyltransferases affect cellular metabolism.
Overexpression
CRISPR activation or lentiviral overexpression can increase enzyme levels to study the effects of enhanced prenyl chain elongation on downstream pathways. Overexpression models are used in metabolic engineering to boost terpenoid production.
How EDITGENE Supports dimethylallyltranstransferase activity Research
Researchers studying dimethylallyltranstransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific metabolic or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for dimethylallyltranstransferase activity research.
Frequently Asked Questions About dimethylallyltranstransferase activity
What is dimethylallyltranstransferase activity?
It is a molecular function (GO:0004161) that catalyzes the condensation of DMAPP and IPP to form geranyl diphosphate and diphosphate.
What genes are involved in dimethylallyltranstransferase activity?
Genes include FDPS, GGPS1, and microbial homologs such as fni and EchPT1.
What is the reaction catalyzed by GO:0004161?
The reaction is: dimethylallyl diphosphate + isopentenyl diphosphate = (2E)-geranyl diphosphate + diphosphate.
How is dimethylallyltranstransferase activity regulated?
It is regulated by feedback inhibition from downstream products, transcriptional control, and substrate availability.
What diseases are associated with dimethylallyltranstransferase activity?
Dysregulation is linked to cancer, metabolic disorders, and infectious diseases.
What are the substrates of dimethylallyltranstransferase?
The substrates are dimethylallyl diphosphate (DMAPP) and isopentenyl diphosphate (IPP).
What is the product of dimethylallyltranstransferase activity?
The product is (2E)-geranyl diphosphate, along with diphosphate.
How can I study dimethylallyltranstransferase activity in the lab?
Enzymatic assays, structural biology, and CRISPR-based genetic models are commonly used.
What are the synonyms for GO:0004161?
Synonyms include geranyl diphosphate synthase activity, DMAPP:IPP-dimethylallyltransferase activity, and trans-farnesyl pyrophosphate synthetase activity.
Why is dimethylallyltranstransferase activity important for drug discovery?
It is a target for anticancer and antimicrobial drugs because it controls prenyl donor supply for protein prenylation and secondary metabolism.
Conclusion
GO:0004161 (dimethylallyltranstransferase activity) is a fundamental enzymatic function that initiates the prenyl chain elongation pathway, supplying essential isoprenoid precursors for protein prenylation, sterol biosynthesis, and natural product production. Its dysregulation is implicated in cancer, metabolic disorders, and infections, making it a compelling target for therapeutic intervention. Advances in structural biology and CRISPR-based genetics continue to illuminate its mechanism and regulation, offering new opportunities for drug discovery and metabolic engineering. Researchers can leverage EDITGENE's CRISPR services to create precise knockout, point mutation, knock-in, and overexpression models, accelerating functional studies of this critical enzyme family.
References
- 1. Han H et al.. 2024. Biochemical characterization of a multiple prenyltransferase from Tolypocladium inflatum.. Appl Microbiol Biotechnol 108(1):275 PMID: 38530470
- 2. Bloor S et al.. 2023. Prenylated flavins: structures and mechanisms.. FEBS J 290(9):2232-2245 PMID: 35073609
- 3. Jung D et al.. 2023. Regulation of protein prenylation.. Biomed Pharmacother 164:114915 PMID: 37236024
- 4. Oshiro T et al.. 2025. Structure-Activity Relationship of an All-α-helical Prenyltransferase Reveals the Mechanism of Indole Prenylation.. Biochemistry 64(19):4196-4205 PMID: 40968638
- 5. Mori T. 2020. Enzymatic studies on aromatic prenyltransferases.. J Nat Med 74(3):501-512 PMID: 32180104
- 6. Awakawa T. 2021. Enzymatic reactions in teleocidin B biosynthesis.. J Nat Med 75(3):467-474 PMID: 33675456
- 7. Higgins PM et al.. 2025. Substrate-Multiplexed Assessment of Aromatic Prenyltransferase Activity.. Chembiochem 26(1):e202400680 PMID: 39317170
- 8. Li W et al.. 2023. Prenylation of dimeric cyclo-L-Trp-L-Trp by the promiscuous cyclo-L-Trp-L-Ala prenyltransferase EchPT1.. Appl Microbiol Biotechnol 107(22):6887-6895 PMID: 37713115
